Media-OutReach Newswire Abivax receives ANSM and Ethics Committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized Phase 2b/3 clinical trial
Life & Style A deadly mix of Covid-19 and superbugs may be the cause of high death rates in Italy – could this also happen in Việt Nam and can it be prevented?